lung injury
Expression, Microbiome Features Provide Pre-Treatment Lung Function Clues for Pediatric Patients
Researchers characterized microbial community and host expression features linked to impaired pulmonary function in children set to receive allogeneic hematopoietic cell transplants.
AlloSure 3.0 can diagnose the very early stages of T-cell mediated rejection, allowing clinicians to begin anti-rejection therapies and monitor treatment.
The company is currently conducting clinical studies to validate AlloSure's technology — which underlies its kidney transplant test — in lung transplant patients.
Liquid Biopsy Dx Looks for Donor-Derived DNA as Measure of Chronic Lung Transplant Rejection
Premium
A team led by researchers at the NHLBI are testing the efficacy of measuring ddcfDNA in blood as a biomarker of chronic rejection for lung transplants.
NEW YORK (GenomeWeb) – Silence Therapeutics this month disclosed that it was ending its work with investigational sepsis drug Atu112 amid disappointing results in preclinical testing.
Apr 11, 2013
Sep 13, 2012
Feb 16, 2012
Jun 2, 2011
Feb 4, 2009